Choon‐Kee Lee
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 12
-
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 3
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Co-authors
- Bart Barlogie (10 shared papers)Guido Tricot (9 shared papers)Maurizio Zangari (9 shared papers)Athanasios Fassas (8 shared papers)Bolin Liu (8 shared papers)Shuiliang Wang (7 shared papers)Elias Anaissie (6 shared papers)Firas Muwalla (3 shared papers)
- Journals
- Blood (5 papers)British Journal of Haematology (4 papers)Cancer Letters (3 papers)Clinical Infectious Diseases (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Choon‐Kee Lee
19 papers receiving 949 citations
Peers
Comparison fields: 5 of 69
- Hematology 585
- Internal Medicine 82
- Oncology 407
- Genetics 96
- Molecular Biology 493
Countries citing papers authored by Choon‐Kee Lee
This map shows the geographic impact of Choon‐Kee Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Choon‐Kee Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Choon‐Kee Lee more than expected).
Fields of papers citing papers by Choon‐Kee Lee
This network shows the impact of papers produced by Choon‐Kee Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Choon‐Kee Lee. The network helps show where Choon‐Kee Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Choon‐Kee Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 170 | |
| 2 | 2005 | 154 | |
| 3 | 2003 | 136 | |
| 4 | 2002 | 129 | |
| 5 | 2002 | 69 | |
| 6 | 2009 | 59 | |
| 7 | 2010 | 45 | |
| 8 | 2013 | 44 | |
| 9 | 2011 | 37 | |
| 10 | 2004 | 29 | |
| 11 | 2004 | 25 | |
| 12 | 2013 | 25 | |
| 13 | 2011 | 20 | |
| 14 | 2003 | 11 | |
| 15 | Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells. | 2013 | 11 |
| 16 | 2004 | 9 | |
| 17 | 2005 | 2 | |
| 18 | 2004 | 2 | |
| 19 | 2012 | 1 |
About Choon‐Kee Lee
Choon‐Kee Lee is a scholar working on Hematology, Molecular Biology, Oncology, Infectious Diseases and Surgery, having authored 19 papers that have together received 978 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer Treatment and Pharmacology (4 papers), Protein Degradation and Inhibitors (3 papers), Peptidase Inhibition and Analysis (3 papers), Bone health and treatments (2 papers), HIV/AIDS drug development and treatment (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Hematology (585 citations), Internal Medicine (82 citations), Oncology (407 citations), Genetics (96 citations) and Molecular Biology (493 citations). Choon‐Kee Lee has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Bart Barlogie, Guido Tricot, Maurizio Zangari, Athanasios Fassas, Bolin Liu, Shuiliang Wang, Elias Anaissie, Firas Muwalla, Frits van Rhee and Xiaoping Huang. Their work appears in journals such as Blood, British Journal of Haematology, Cancer Letters, Clinical Infectious Diseases and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.